Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtrer
1.
J Thorac Cardiovasc Surg ; 164(1): 42-51.e2, 2022 07.
Article de Anglais | MEDLINE | ID: mdl-32891451

RÉSUMÉ

OBJECTIVES: Insufficient distance between membranous septum (MS) length and implant depth (ID) may aggravate mechanical compression of the conduction tissue by transcatheter aortic valve replacement (TAVR) prosthesis. We investigated the implication of MS length measured in the coronal view (coronal MS length) compared with infra-annular MS length from stretched vessel image to predict conduction disturbances following TAVR with CoreValve/Evolut R valves (Medtronic, Minneapolis, Minn). METHODS: Among 195 consecutive patients undergoing TAVR with CoreValve/Evolut R valves, we evaluated coronal, infra-annular MS lengths and ID, as well as MS length minus ID (ΔMSID) using pre-TAVR computed tomography and postprocedural angiography. RESULTS: Within 30 days, 6 (3.1%) required permanent pacemaker implantation and 31 (16.4%) developed left bundle branch block. When taking into account pre- and postprocedural parameters, multivariable logistic regression analysis revealed either coronal ΔMSID (odds ratio, 0.80; 95% confidence interval, 0.72-0.89; P < .001; cutoff point, 3.2 mm) or infra-annular ΔMSID (odds ratio, 0.84; 95% confidence interval, 0.76-0.92; P < .001; cutoff point, -0.2 mm) emerged as the only modifiable predictor of conduction disturbances. The area under the curve of coronal ΔMSID and infra-annular ΔMSID for predicting the occurrence of conduction disturbances were comparable (0.717 in coronal ΔMSID vs 0.708 in infra-annular ΔMSID; P = .761), but more patients could be guided by coronal MS length than infra-annular MS length (95.9% vs 87.2%; P = .002). CONCLUSIONS: Preprocedural assessment of MS length should be routinely adopted to determine the optimal ID to mitigate individual patient susceptibility to conduction disturbances after TAVR with self-expanding valves.


Sujet(s)
Sténose aortique , Prothèse valvulaire cardiaque , Pacemaker , Remplacement valvulaire aortique par cathéter , Valve aortique/imagerie diagnostique , Valve aortique/chirurgie , Sténose aortique/imagerie diagnostique , Sténose aortique/chirurgie , Entraînement électrosystolique , Humains , Conception de prothèse , Facteurs de risque , Remplacement valvulaire aortique par cathéter/effets indésirables , Résultat thérapeutique
2.
Int J Mol Sci ; 18(6)2017 May 31.
Article de Anglais | MEDLINE | ID: mdl-28561778

RÉSUMÉ

Enhancer of zeste homolog 2 (EZH2), a histone methyltransferase, catalyzes tri-methylation of histone H3 at Lys 27 (H3K27me3) to regulate gene expression through epigenetic machinery. EZH2 functions as a double-facet molecule in regulation of gene expression via repression or activation mechanisms, depending on the different cellular contexts. EZH2 interacts with both histone and non-histone proteins to modulate diverse physiological functions including cancer progression and malignancy. In this review article, we focused on the updated information regarding microRNAs (miRNAs) and long non coding RNAs (lncRNAs) in regulation of EZH2, the oncogenic and tumor suppressive roles of EZH2 in cancer progression and malignancy, as well as current pre-clinical and clinical trials of EZH2 inhibitors.


Sujet(s)
Protéine-2 homologue de l'activateur de Zeste/génétique , Régulation de l'expression des gènes tumoraux , microARN/génétique , Tumeurs/génétique , ARN long non codant/génétique , Évolution de la maladie , Protéine-2 homologue de l'activateur de Zeste/antagonistes et inhibiteurs , Antienzymes/usage thérapeutique , Humains , Mutation , Tumeurs/traitement médicamenteux , Tumeurs/anatomopathologie , Protéines suppresseurs de tumeurs/génétique
3.
PLoS One ; 9(6): e100105, 2014.
Article de Anglais | MEDLINE | ID: mdl-24936861

RÉSUMÉ

This study aimed to investigate the anti-allergic effects of Lactobacillus plantarum K37 (K37) on airway hyperresponsiveness (AHR) and systemic allergic responses in ovalbumin (OVA)-sensitized and -challenged BALB/c mice. Heat-inactivated K37 (105, 107, and 109 CFU/mouse, day) were orally administered to OVA-sensitized BALB/c mice to investigate their effects on AHR, immunoglobulin (Ig) and cytokine production. The results showed that K37 dose-dependently lowered the serum levels of IgE, OVA-specific IgE and OVA-specific IgG1, ameliorated AHR induced by methacholine and suppressed eosinophil infiltration in bronchoalveolar lavage fluid (BALF). The cytokine production in spleen cells culture and BALF showed that K37 drove the immune responses toward T-helper cell type 1 (Th1) responses, elevated levels of IL-2 and IFN-γ, and reduced of IL-4, IL-5 and IL-13. K37 also improved cell infiltration in lung sections. Our results demonstrated that oral administration of K37 alleviated effectively the allergic responses in vivo. Thus, K37 can be a good source material and a promising candidate for prophylactic and therapeutic treatments of allergic diseases, like asthma.


Sujet(s)
Hypersensibilité/thérapie , Lactobacillus plantarum/immunologie , Poumon/immunologie , Administration par voie orale , Animaux , Cytokines/analyse , Femelle , Hypersensibilité/immunologie , Hypersensibilité/anatomopathologie , Immunoglobulines/sang , Poumon/anatomopathologie , Poumon/physiopathologie , Souris , Souris de lignée BALB C , Ovalbumine/immunologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE